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Introduction
Secondary amenorrhea is defined as absence of men-
struation for three normal menstrual cycles or 6 months.
In non-pregnant women, secondary amenorrhea may
result from polycystic ovary syndrome (PCOS), thyroid
disease, premature ovarian failure, hypothalamic dys-
function, pituitary dysfunction, or Asherman syndrome
[1]. One series of 188 patients with secondary amenor-
rhea in Taiwan were studied, with the major etiologic
factors revealing hypothalamic-pituitary dysfunction
(34%), hyperprolactinemia (19.7%), polycystic ovary
disease (13.3%), and premature ovarian failure (12.2%)
[2]. Here, we report a case of secondary amenorrhea
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SUMMARY
Objective: Here, we present a case of ACTH-dependent pituitary macroadenoma (Cushing’s disease) resulting
in secondary amenorrhea mimicking polycystic ovary syndrome (PCOS).
Case Report: A 20-year-old nulligravid woman had been suffering from oligomenorrhea, amenorrhea, and
moderate hirsutism since the age of 18 years. She visited a gynecologic clinic where PCOS was impressed according
to the clinical manifestation and ultrasound finding. The patient responded to medication in the 1st year, but grad-
ually failed to induce menses. She was advised to visit the endocrinology department for secondary amenorrhea
and endocrine survey. Physical examination revealed central obesity, supraclavicle fatpad, abdominal striae, and
myopathy of four limbs. Endocrine studies revealed: serum prolactin 21 ng/mL (3.0–20 ng/mL), FSH 5.69 mIU/mL
(3.4–10.0 mIU/mL), LH 1.01 mIU/mL (1.1–11.6 mIU/mL), E2 < 20 pg/mL (follicular phase 53–258 pg/mL), ACTH
110 pg/mL (0–46.0 pg/mL), cortisol 26.7g/dL at 8 a.m. (5.0–25g/dL), cortisol 21.3g/dL at 11 p.m. (half of
normal morning value). Right pituitary macroadenoma was diagnosed through a series of dexamethasone tests
and MRI. The patient received staging surgery including  transsphenoidal adenomectomy and right frontotempo-
ral craniotomy. As a result, the patient’s physical condition gradually improved, and her menstrual cycle became
regular with medication after the operation in the outpatient follow-up.
Conclusion: PCOS is a common disease resulting in secondary amenorrhea. However, Cushing’s syndrome result-
ing from pituitary macroadenoma should also be considered. Therefore, a careful history, observation, physical
examination, and endocrine studies can differentiate between patients with PCOS and Cushing’s disease. [Taiwanese
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■ SHORT COMMUNICATION ■
due to ACTH-dependent pituitary macroadenoma, and
its clinical manifestations mimicking PCOS.
Case Report
The subject was a 20-year-old nulligravid woman whose
menarche had occurred at the age of 13 years with reg-
ular monthly periods for 4 years. During this period,
there was no usage of oral contraceptives or dysmen-
orrhea. The patient’s periods had gradually reduced to
three to four times a year and she even had amenorrhea
since the age of 18 years. Additional symptoms, such
as moderate hirsutism and acne, have been present
since that time. Owing to the above symptoms, she vis-
ited a gynecologic clinic for further evaluation. During
her stay, history was taken and ultrasound sonography
of the lower abdomen revealed multiple and small periph-
eral cysts in the ovaries. Serum prolactin level was within
the normal range. PCOS was impressed according to the
clinical manifestation and ultrasound finding. Proges-
terone was prescribed. The patient responded to the
medication during the 1st year, but it then gradually
failed to induce periods. Moreover, her weight increased
by 25 kg (from 52 to 77 kg) within a 3-year period. She
was then referred to the endocrinology department for
both secondary amenorrhea and endocrine survey.
Physical examination at the endocrinology department
revealed central obesity (165 cm, 77 kg, body mass index
28.28 kg/m2), moon face, buffalo hump, supraclavicle
fatpad, abdominal striae, and myopathy of four limbs.
The patient denied any headache, scalp hair loss, or
galactorrhea. Endocrine studies revealed: serum pro-
lactin 21 ng/mL (3.0–20 ng/mL), FSH 5.69 mIU/mL
(3.4–10.0 mIU/mL), LH 1.01 mIU/mL (1.1–11.6 mIU/
mL), E2 < 20 pg/mL (follicular phase 53–258 pg/mL),
TSH 1.06IU/mL (0.4–4.0IU/mL) and free T4
10.3 ng/dL (7–19 pg/mL), ACTH 110 pg/mL (0–46.0 pg/
mL), cortisol 26.7g/dL at 8 a.m. (5.0–25g/dL),
cortisol 21.3g/dL at 11 p.m. (half of normal morning
value). The other cortisol levels were 9.86g/dL and
4.11g/dL after 1 mg overnight dexamethasone sup-
pression test and low-dose dexamethasone suppression
test, respectively (normal range should be suppressed
below 1.8g/dL). Then, right pituitary macroadenoma
(Cushing’s disease) was diagnosed using MRI (Figure 1).
Otherwise, no visual field defect or visual acuity loss
was found following ophthalmologic consultation. We
concluded that the patient’s symptoms might possibly
result from hypercortisolism. We consulted with the
neurosurgeon, and staging surgery including trans-
sphenoidal adenomectomy and right frontotemporal
craniotomy with removal of the tumor were performed.
The pathology report revealed corticotroph macroade-
noma (Figure 2). Postoperatively, the patient’s physical
condition gradually improved and the menstrual cycle
has returned to regularity with medication administered
during outpatient follow-up.
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Figure 2. Tumor cells show diffuse growth pattern and are
round to oval in shape, with pale to eosinophilic granular
cytoplasm. The background is also highly vascularized. Tumor
cells stained positively for ACTH after immunohistochemical
staining (200, H&E).
Figure 1. MRI of sella (T1W1 with contrast medium) showed
a right pituitary macroadenoma about 442319 mm in
size. The tumor showed obvious extrasellar extension, com-
pressed the hypothalamus and optic chiasm, and encased the
right internal carotid artery.
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Discussion
Cushing’s disease is unlike prolactinomas, which are
the most common form of pituitary adenoma, making
up approximately one-third of all pituitary neoplasms
[3]. Statistics show that it is a rare condition observed
in about 8–10% of patients with pituitary tumor, and 
it has been estimated that about 1.2–1.7 new cases 
per million population present each year. In the major-
ity of cases, ACTH-secreting pituitary microadenomas
are small, intrasellar, and < 10 mm in diameter, while
macroadenomas occur rarely and only in 4–10% of pa-
tients [4,5]. In contrast, ACTH-independent Cushing’s
syndrome (adrenal adenoma) is currently the most 
frequently found etiology in Taiwan [6] compared to
ACTH-dependent pituitary macroadenoma, which is
an uncommon case resulting in Cushing’s syndrome.
PCOS is a common reproductive endocrine and
menstrual cycle disorder; about 5% of women in the
population have been affected by it, even though its 
etiology and pathogenesis are not completely under-
stood [7]. PCOS can be diagnosed when other medical
conditions that cause irregular periods and androgen
excess have been excluded, and when at least two of the
following are present: oligoovulation or anovulation, ele-
vated levels of circulating androgens or clinical manifes-
tations of androgen excess, and/or polycystic ovaries as
defined by ultrasonography [8,9]. However, many of the
presenting features of women with Cushing’s syndrome
are similar to those observed in patients with PCOS:
obesity, hirsutism, insulin resistance, low serum sex
hormone-binding globulin levels, increased circulating
androgen levels, etc. [10]. Most patients with Cushing’s
syndrome (about 80%) have irregular periods includ-
ing oligomenorrhea or amenorrhea [10]. Patients with
hypoestrogenic amenorrhea react normally to serum
TSH, prolactin, FSH levels and have no uterine bleeding
to progesterone challenge, so hypothalamic-pituitary
lesion should also be considered [1,3]. In contrast,
PCOS may have uterine bleeding to progesterone chal-
lenge even if the endocrine study showed normal TSH,
prolactin, FSH, and estradiol. The histologic appearance
of ovaries in Cushing’s disease is distinct from that in
PCOS. In Cushing’s syndrome, there is a marked reduc-
tion in all phases of primordial follicles, an absence of
cortical stromal hyperplasia, reduction in size, and sug-
gestion of a lack of gonadotropic stimulation [10]. On
the other hand, women who have PCOS have ovaries
that are two to five times macroscopically greater in size
than normal [1]. The menstrual disturbances associ-
ated with Cushing’s syndrome may be a consequence 
of the disturbed hypothalamic GnRH secretion in-
duced by chronic hypercortisolemia [10]. Glucocorticoid
receptors have been localized to granulose cells and
GnRH neurons. Chronic hypercortisolemia blocks both
the action of gonadotropins in the gonads and the
secretion from the hypothalamus of GnRH [10,11]. We
suggest that menstrual abnormalities in women with
Cushing’s disease may be related to the high circulating
serum cortisol levels and not to the circulating levels of
serum androgens. Therefore, screening for hypercorti-
solism is often required in patients with PCOS  whose
clinical manifestation mimic those of Cushing’s syn-
drome [11]. Putignsno et al suggest that the 1-mg 
dexamethasone suppression test and midnight cortisol
level are unaffected by the presence of PCOS and 
can be safely used to screen for Cushing’s syndrome in
premenopausal obese women with PCOS [12].
Our patient experienced irregular periods for about 2
years and PCOS was impressed according to the clinical
manifestation and ultrasound finding. However, her
menstrual cycle did not return to normal despite med-
ication. In addition, endocrine studies revealed non-
suppressible cortisol level after dexamethasone test, high
serum ACTH, and hypogonadotropic hypogonadism.
Therefore, Cushing’s disease should be considered in the
differential diagnosis, particularly in the presence of
other features such as hypertension, myopathy, and easy
bruising [11].
In conclusion, PCOS is a common disease resulting
in secondary amenorrhea. With the several facts stated
above, we learned that a careful history, observation,
physical examination, and some endocrine studies can
usually diagnose patients with PCOS who have men-
strual abnormalities due to Cushing’s disease or other
underlying disease.
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